Written and maintained by CASRAI Editorial Board
Last updated
Most organisations that reach for an evidence-based practice (EBP) model already have one in mind — usually whichever one a nurse leader or DNP programme happened to teach them. That works fine until the question in front of the team doesn’t match the model’s actual job. The Iowa Model, Johns Hopkins Nursing EBP (JHNEBP), PRECEDE-PROCEED, RE-AIM, and CFIR are all real, widely used frameworks — but they answer five genuinely different questions, and using the wrong one doesn’t just waste time, it produces the wrong kind of output for whatever decision or documentation the organisation actually needs next.
This guide doesn’t re-explain any one model’s internal mechanics — each has its own full walkthrough linked above. Instead it’s a selection framework: three questions that, answered honestly, point to the right model (or right combination of models) for your situation.
The Three Questions That Actually Decide Fit
1. What kind of question are you actually asking?
Every EBP/implementation-science framework is built around one core type of question. Naming yours first is the fastest way to eliminate four of the five models immediately.
- “Should we adopt this specific practice change, here, now?” — a decision question, tied to a trigger someone on the unit noticed. This is what Iowa and JHNEBP are built for.
- “What should a new programme even target, and why?” — a diagnostic-design question, asked before any intervention exists. This is PRECEDE-PROCEED‘s entire front half.
- “How well is this intervention actually performing once it’s out in the world?” — an evaluation question, asked about something already built and running (or piloted). This is RE-AIM.
- “Why is this implementation struggling, and what’s helping or hurting it?” — a determinant question about context, not about the evidence or the outcome. This is CFIR.
Note what’s not on this list: none of the five is a general-purpose “EBP model” in the sense of being interchangeable with the others. Organisations that pick one model and try to force every EBP question through it usually end up bending the model past what it was designed to answer.
2. Where are you in the timeline — before, during, or after the intervention exists?
This is the single fastest filter, because it’s almost mechanical:
- Before anything exists and you’re designing a programme from a community- or population-level problem: PRECEDE-PROCEED’s assessment phases (1–4) are the only one of the five built to run at this stage.
- You have a specific, already-formed practice question (a unit is doing X, evidence suggests Y might be better) and need a documented path from question to a go/no-go decision: Iowa or JHNEBP.
- An intervention or practice change is selected and either about to start or already underway, and you need to understand what’s making it hard to embed: CFIR, which can be applied prospectively (as a pre-implementation interview guide) or concurrently (to diagnose why adoption is stalling).
- The intervention has already been delivered, in a pilot or at scale, and you need to report on its real-world reach and durability: RE-AIM.
The practical implication: CFIR and RE-AIM are not starting points for “we haven’t decided what to do yet.” They both assume a specific intervention or practice change is already the subject — CFIR asks what’s getting in its way, RE-AIM asks how well it’s doing.
3. Do you need a built-in evidence-appraisal tool, or are you supplying that yourself?
This is the dimension most comparisons skip, and it’s often the deciding one for a Magnet or Pathway to Excellence documentation trail. Of the five models:
- JHNEBP is the only one that ships a formal, dedicated appraisal system — the Research Evidence Appraisal Tool and the Non-Research Evidence Appraisal Tool, each resolving a source to a Level (I–V, by evidence type) and a Quality grade (A/B/C, by execution). If your organisation needs a standardised, reproducible way to grade every piece of evidence a practice question turns up, this is the practical reason teams choose JHNEBP over Iowa.
- Iowa expects a critical-appraisal step as part of its “is there sufficient evidence?” decision gate, but it doesn’t bundle a proprietary grading instrument the way JHNEBP does — teams typically bring their own appraisal checklist (or the JHNEBP tools) to that gate.
- PRECEDE-PROCEED, RE-AIM, and CFIR aren’t evidence-appraisal tools at all, and it’s a category error to expect one from them. PRECEDE-PROCEED appraises a population’s needs, not a study’s rigor. RE-AIM measures an intervention’s real-world performance, not the quality of the evidence behind it. CFIR rates contextual constructs as barriers or facilitators, not evidence quality.
If your organisation’s real requirement is “we need a documented Level/Quality grade on every piece of evidence we cite,” that alone is often enough to settle the choice in JHNEBP’s favour over Iowa, independent of anything else about the two models’ decision pathways.
Side-by-Side Comparison
| Model | Core question | Unit of analysis | When you’d reach for it | Built-in appraisal tool | Typical output |
|---|---|---|---|---|---|
| Iowa Model | Should we adopt this specific practice change? | Unit / organisation | A trigger has been identified; need a documented go/no-go path | No (expects an external appraisal step) | A decided, piloted, and (if adopted) diffused practice change |
| JHNEBP | What does the evidence say, how strong is it, and how do we translate it? | Unit / organisation | Same as Iowa, plus a need for graded, documented evidence appraisal | Yes — Research & Non-Research Appraisal Tools (Level + Quality) | A Level/Quality-graded evidence table and a translation recommendation |
| PRECEDE-PROCEED | What should a new programme target, and why? | Community / population | Before an intervention exists; designing a programme from scratch | No (diagnostic, not evidence-appraisal) | A ranked predisposing/reinforcing/enabling factor matrix and a programme design |
| RE-AIM | How well is this existing intervention performing? | Intervention / programme | After delivery or pilot; reporting for publication, dissemination, or a funder | No (evaluation, not appraisal) | Reach, Effectiveness, Adoption, Implementation, and Maintenance figures |
| CFIR | What contextual factors are helping or hindering implementation? | Intervention within its setting | Before or during rollout; implementation is stalling or strategy selection is needed | No (determinant framework, not appraisal) | A construct-by-construct barrier/facilitator profile |
Decision Guide by Scenario
“A charge nurse noticed something and wants to know if a specific practice should change.”
Start with Iowa if the unit just needs a documented decision pathway with clear go/no-go gates. Choose JHNEBP instead if the organisation also needs every source graded on a standard Level/Quality scale — for instance, to feed a Magnet or Pathway to Excellence evidence trail, where a reviewer will expect to see how each source was appraised, not just cited.
“We’re designing a new community health programme and haven’t built anything yet.”
PRECEDE-PROCEED is the only one of the five built to run this early. Its first four phases exist specifically to diagnose what a population needs before a single intervention component is chosen — neither Iowa nor JHNEBP has an equivalent front-end diagnostic stage, and RE-AIM/CFIR both assume something already exists to evaluate or diagnose.
“We need to report how well a pilot performed, for a paper or a funder.”
RE-AIM is purpose-built for this. It gives reviewers and funders a standardised, comparable vocabulary for an intervention’s real-world reach and durability that a narrative summary doesn’t.
“A practice change was approved months ago and still isn’t sticking.”
This is CFIR territory: it diagnoses which contextual constructs (across the Innovation, Outer Setting, Inner Setting, Individuals, and Implementation Process domains) are working against adoption, which can then be matched to specific implementation strategies. It’s a repair tool for a stalled rollout, not a starting point for deciding whether to make the change in the first place.
“We just need a mentor-supported model an individual clinician can use on their own.”
None of the five profiled here is built primarily around individual mentorship the way the ARCC (Advancing Research and Clinical practice through close Collaboration) model is, if that’s the actual requirement; Iowa and JHNEBP are both still usable by an individual clinician, but neither treats a dedicated EBP mentor as the model’s active ingredient.
These Models Are Not Mutually Exclusive
Organisational fit isn’t always “pick exactly one.” Some of the most common real applications combine two of these frameworks, each doing the part it’s actually built for:
- PRECEDE-PROCEED to design, RE-AIM to report. A team can run PRECEDE-PROCEED’s Phases 1–4 to diagnose and design an intervention, deliver it, then report on it using RE-AIM’s five dimensions instead of (or alongside) PRECEDE-PROCEED’s own evaluation phases 6–8.
- CFIR mid-pathway inside an Iowa or JHNEBP rollout. If a decision has already cleared Iowa’s or JHNEBP’s gates and adoption is the part that’s failing, CFIR’s determinant domains give the team a structured way to find out why, without re-litigating whether the practice change itself was the right call.
- JHNEBP’s appraisal tools inside another model’s evidence step. Because Iowa doesn’t bundle its own grading instrument, some organisations that prefer Iowa’s decision-gate structure still borrow JHNEBP’s Research/Non-Research Appraisal Tools for the “is there sufficient evidence?” gate specifically.
What doesn’t combine cleanly: using RE-AIM or CFIR as a substitute for a diagnostic-design step, or expecting PRECEDE-PROCEED to grade evidence quality the way JHNEBP does. Each model’s blind spot is real, not just a matter of emphasis.
A Short Self-Check
- Does the intervention or practice change already exist, even as a pilot? If no, start with PRECEDE-PROCEED. If yes, continue.
- Is the open question “should we do this” or “why isn’t this sticking / how well is it doing”? If the former, go to Iowa or JHNEBP. If the latter, continue.
- Are you trying to explain adoption problems in context, or measure real-world performance for reporting? Context problems point to CFIR; performance reporting points to RE-AIM.
- If you landed on Iowa or JHNEBP: does your documentation trail require a standardised Level/Quality grade on every source? If yes, JHNEBP. If a documented decision pathway is enough on its own, Iowa.
Frequently Asked Questions
Is there one “best” evidence-based practice model?
No — the five profiled here answer different questions and none is a superset of the others. “Best” only makes sense relative to the specific question, timeline stage, and documentation requirement in front of the organisation.
Can an organisation use more than one model at once?
Yes, and it’s common in practice. PRECEDE-PROCEED paired with RE-AIM (design, then evaluate) and CFIR paired with Iowa or JHNEBP (decide, then diagnose why adoption is lagging) are both established combinations, not workarounds.
Does Magnet or Pathway to Excellence require a specific model?
Neither designation mandates one named EBP model by name; both expect a documented, evidence-based decision trail. See the Magnet designation guide for what the appraisal process actually looks for. In practice, organisations frequently choose JHNEBP specifically because its built-in Level/Quality appraisal tools produce exactly the kind of documented evidence trail a Magnet reviewer expects to see.
What if different units in the same organisation prefer different models?
That’s workable as long as the choice tracks the actual question each unit is asking rather than habit. A shared nursing research or EBP council, where one exists, is a reasonable place to keep that consistent without forcing every unit onto the same model regardless of fit.
We don’t have a formal EBP mentor. Does that rule out any of these five?
Not directly — none of Iowa, JHNEBP, PRECEDE-PROCEED, RE-AIM, or CFIR requires a dedicated mentor role the way the ARCC model does. A mentor still helps any of them run better, but its absence is more of a constraint on execution speed than a disqualifying factor for any one model.
Related Reading
- The Iowa Model of Evidence-Based Practice: The Full Decision Pathway
- Johns Hopkins Nursing EBP Model: The PET Process and Evidence Appraisal Tools
- The PRECEDE-PROCEED Model: What Each of the 8 Phases Produces
- RE-AIM Framework: How to Measure Each of the Five Dimensions
- The Consolidated Framework for Implementation Research (CFIR)
- Magnet Designation Requirements and the Appraisal Process
- Levels of Evidence: The OCEBM 2011 Table, GRADE, and Where the Pyramid Breaks
- Research Methods & Statistics








